Hepatocellular carcinoma (HCC) is the fourth leading cause of cancer-related mortality and
has an increasing incidence worldwide. Locoregional therapies, defined as imaging-guided …

Minimally invasive thermal ablation of tumours has become common since the advent of
modern imaging. From the ablation of small, unresectable tumours to experimental …

Tumor ablation technologies, such as radiofrequency-, cryo-or high-intensity focused
ultrasound (HIFU) ablation will destroy tumor tissue in a minimally invasive manner. Ablation …

Thermal ablative therapies are standard treatments for localized hepatocellular carcinoma
(HCC). In addition to local tumor destruction, ablation leads to abscopal effects in distant …

Over the past decades, thermoablative techniques for the therapy of localized tumors have
gained importance in the treatment of patients not eligible for surgical resection. Anecdotal …

Percutaneous image‐guided ablation is an increasingly common treatment for a multitude of
solid organ malignancies. While historically these techniques have been restricted to the …

Metastatic liver disease is the most common cause of death in cancer patients. Complete
surgical resection is currently considered the only curative treatment, with only about 25% of …

Image-guided tumor ablation for early stage hepatocellular carcinoma (HCC) is an accepted
non-surgical treatment that provides excellent local tumor control and favorable survival …

Purpose. Irreversible electroporation (IRE) has been demonstrated to be a safe and effective
method for locally advanced pancreatic cancer (LAPC). The aim of this study was to …

Over the last several decades, a number of new treatment options for patients with
hepatocellular carcinoma (HCC) have been developed. While treatment decisions for some …